Design (Testphase)
Risk & Weakness
RS Weakness (≤10)
159
Findings
July 21, 2026
last calculated
Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Market filter active: the list shows 25 hits from US
Relative strength rating ≤ 10 — the weakest ~10% relative to the market.
Global filters: 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); fundamentally healthy names (Piotroski ≥ 5 or Funda Rating ≥ +10) are excluded.
🔔 Watch scanner
Terms in This Scanner Explained
(16)
- ADR (Average Daily Range)
- The average daily swing of a stock in percent - measured over 10 or 30 trading days (columns "ADR 10D/30D"). An ADR of 5% means: on a normal day the gap between the intraday low and high runs about 5%. Traders look for movement - that is why stocks with an ADR under 1% are filtered out globally. Not to be confused with ADR meaning "American Depositary Receipt" (a US certificate for foreign shares) - here ADR always means the daily swing.
- AI Classification
- Our company-by-company assessment of the AI boom based on SEC filings (the last four quarterly 10-Q reports and two annual 10-K reports): "Sells AI" (AI is a revenue source), "Threatened" (AI is a concrete business risk), "Uses AI" (operational use), or "Neutral" (no material AI exposure). Every classification requires at least two direct quote citations - otherwise the column shows "-". Not a quality judgment or a buy recommendation; the full file is on the stock page, methodology at /stocks/ai-rating-methodology.
- Analysis (Full Company Analysis)
- If the Analysis column shows "Read," there is an in-depth Minnow Street company analysis for this stock: business model, scanner findings, quarterly results, evidence from SEC filings, plus opportunities and risks. One click opens it directly.
- Avg/Yr 3Y (Average Annual Return)
- The stock's average annual return over the past 3 years. Shows at a glance whether a stock delivers over the long run or just had a short hot streak.
- Earnings Date
- The date of the next quarterly earnings report. Price gaps in either direction are common around this date - that is why we color it red when it is 7 days away or less, and yellow when it is 14 days away or less: elevated risk for fresh positions.
- EPS (Earnings per Share)
- Quarterly earnings divided by the number of shares outstanding. The most important growth metric: if EPS rises strongly over several quarters, the company is earning more money per share.
- Free Cash Flow (FCF)
- Operating cash flow minus capital expenditures - the money left over for everything else (debt paydown, acquisitions, or buybacks). Consistently positive free cash flow is one of the most honest signs of a healthy business model.
- Funda Rating (Fundamental Rating A+ to F)
- Our proprietary fundamental rating from -100 to +100 with a school-grade rank from A+ to F. Every stock is scored against all others by percentile: growth in earnings and revenue, earnings surprises, analyst estimates, and quality criteria such as margins, cash flow, and balance-sheet strength. A/A+ are the fundamentally strongest stocks in the universe.
- Market Capitalization (Mkt Cap)
- The market value of the company: share price x total shares outstanding, shown here in billions of dollars. Micro caps (< $0.3B) are small and volatile, mega caps (> $200B) are heavyweights. Our scanner universe is deliberately capped at $50B - we look for stocks with room to run.
- Net Margin
- How much of revenue is left as profit? Net income divided by revenue, in percent. A 20% margin means: out of every dollar of revenue, 20 cents is left as profit. Rising margins are a strong quality signal.
- Operating Cash Flow (OCF)
- The cash that actually flows into the company from day-to-day operations - without accounting effects such as depreciation. A company can report book profits while still burning cash; operating cash flow reveals that.
- Piotroski F-Score
- A balance-sheet health check developed by Joseph Piotroski: 9 yes/no criteria covering earnings, cash flow, leverage, and efficiency produce a score from 0 to 9. Scores of 7 or higher are considered financially very solid, scores under 3 a warning sign.
- Relative Strength (RS Rating)
- How much has a stock risen compared with every other stock? The RS Rating is a percentile from 1 to 99: RS 90 means the stock has outperformed 90% of all stocks (depending on the scanner, over 1 week, 1, 3, 6, or 12 months). Market leaders almost always carry high RS values - that is why relative strength is the core of many momentum strategies.
- Sector & Industry
- Two levels of industry classification: sector is broad (e.g., Technology), industry is narrow (e.g., Semiconductors). Many strategies watch industry strength, because strong stocks are almost always found in strong industries.
- Stage (Weinstein Stages 1-4)
- Stan Weinstein divides every price chart into four stages: Stage 1 = basing (sideways after a downtrend), Stage 2 = uptrend (the only buying stage), Stage 3 = topping, Stage 4 = downtrend (avoid, or short candidate). Measured against the 30-week line (150-day moving average) and its slope.
- Stress RS (Strength on Stress Days)
- A stress day is a day on which both the overall market and the stock's own sector fell at least 0.5%. Stress RS counts on how many of these days the stock still closed green (shown as "g/n" = green days out of n stress days) and turns that into a rating from 1 to 99. High values point to buyers stepping in even on weak days - often a sign of institutional accumulation.
Hit List
Filter ▾
Rating (traffic light)
Stage
Funda Rating
Piotroski
Columns ▾
This scanner's columns
Extra columns
Tip: clicking a column header sorts the table by that column; a second click flips the direction.
| Symbol | Earnings | Avg/Y 3Y | Stress RS | Stage | Funda Rating | Piotroski | MktCap | Industry | AI Rating | Deep Dive | Deep-Dive Report | Sector | Price | YTD | 6 Mo. | 1 Year | Off High | Price Target | RS | EPS Rating | ADR 10D | ADR 30D | Beta | P/E | P/E (f) | P/S | P/B | P/FCF | PEG | EV/EBITDA | EBIT Margin | Gross Margin | Net Margin | ROE | ROA | Debt/Eq | Equity Ratio | Sales +/Y | Div. Yield | Payout Ratio | Altman Z | Inst. % | Short % | Analysts |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TEAM Atlassian Corp Plc | 08/06 | -17 % | 45 5/25 | Stage 4 | C +3 | 4 of 9 | 18.9 | Software - Application | – | — | — | Technology | 96.40 $ | -49.8 % | -50.8 % | -57.7 % | −66.5 % | +88.0 % | 10 | 89 | 6.0 % | 7.1 % | 1.11 | — | 12.8 | 3.1 | 21.6 | 15.7 | 0.64 | 2,349.9 | 9.4 % | 84.8 % | -3.5 % | -19.3 % | 0.5 % | -0.87 | 15.6 % | +19.7 % | 0.0 % | 0.0 % | -1.3 | 108.9 % | 10.7 % | 1.2 (33) |
| DOX Amdocs Ltd | 08/05 | -14 % | 34 4/25 | Stage 4 | C -5 | 4 of 9 | 5.3 | Software - Infrastructure | – | — | — | Technology | 53.20 $ | -34.4 % | -35.8 % | -42.2 % | −46.6 % | +62.8 % | 10 | 26 | 3.8 % | 3.4 % | 0.43 | 10.0 | 6.3 | 1.1 | 1.6 | 7.8 | 0.70 | 6.8 | 16.5 % | 37.8 % | 11.8 % | 15.9 % | 8.2 % | 0.32 | 53.2 % | -9.4 % | 4.4 % | 30.7 % | 9.0 | 100.8 % | 10.2 % | 1.4 (5) |
| ELF ELF Beauty Inc | 08/05 | -14 % | 79 5/16 | Stage 4 | C +1 | 2 of 9 | 3.8 | Household & Personal Product | – | — | — | Consumer Defensive | 79.70 $ | -16.5 % | -12.3 % | -47.6 % | −56.9 % | +10.4 % | 10 | 87 | 6.1 % | 6.3 % | 2.39 | 147.9 | 23.1 | 2.3 | 3.4 | 20.1 | 1.37 | 32.2 | 1.7 % | 61.0 % | -0.2 % | -0.3 % | 4.1 % | 0.81 | 47.2 % | +24.6 % | 0.0 % | 0.0 % | 5.5 | 101.3 % | 21.9 % | 1.3 (17) |
| ACHR Archer Aviation Inc | 08/10 | +18 % | 17 3/29 | Stage 4 | D -35 | 4 of 9 | 3.7 | Aerospace & Defense | – | — | — | Industrials | 5.30 $ | -30.2 % | -42.4 % | -49.5 % | −67.2 % | +121.5 % | 10 | 42 | 6.9 % | 7.1 % | 3.19 | — | 0.0 | 1,954.2 | — | — | — | -0.4 | -15,762.5 % | 15.8 % | 0.0 % | -48.1 % | -29.6 % | — | 89.5 % | -100.0 % | 0.0 % | 0.0 % | 11.8 | 49.2 % | 18.6 % | 1.2 (9) |
| SOUN SoundHound AI Inc | 08/06 | +25 % | 20 3/25 | Stage 4 | D -20 | 2 of 9 | 2.7 | Software - Application | – | — | — | Technology | 6.30 $ | -35.4 % | -41.3 % | -33.2 % | −72.0 % | +125.4 % | 10 | 42 | 6.4 % | 6.3 % | 2.81 | — | 227.3 | 14.8 | — | — | — | 135.8 | -139.3 % | 40.6 % | -91.8 % | -39.4 % | -19.7 % | — | 71.4 % | +99.5 % | 0.0 % | 0.0 % | 1.4 | 44.9 % | 40.6 % | 1.4 (8) |
| COUR Coursera Inc | 07/23 | -19 % | 27 2/16 | Stage 4 | C +5 | 3 of 9 | 1.6 | Education & Training Service | – | — | — | Consumer Defensive | 5.50 $ | -26.5 % | -24.1 % | -27.8 % | −57.5 % | +37.2 % | 10 | 42 | 5.5 % | 5.6 % | 1.23 | — | 10.7 | 2.1 | — | 19.3 | — | -7.5 | — | 54.8 % | -8.2 % | -10.3 % | -4.9 % | — | — | +9.0 % | 0.0 % | 0.0 % | 5.1 | 69.9 % | 8.8 % | — |
| ALKT Alkami Technology Inc | 07/29 | -1 % | 34 4/25 | Stage 4 | C +1 | 4 of 9 | 1.6 | Software - Application | – | — | — | Technology | 18.00 $ | -34.8 % | -26.1 % | -45.1 % | −49.0 % | +37.1 % | 10 | 42 | 4.8 % | 5.1 % | 0.56 | — | 0.0 | 3.5 | 4.4 | 37.1 | — | -50.7 | — | 57.8 % | -10.5 % | -14.1 % | -3.2 % | 0.97 | — | +32.9 % | 0.0 % | 0.0 % | 2.4 | 98.5 % | 12.6 % | — |
| ONT Onterris | 08/05 | -19 % | — | Stage 4 | C 0 | 3 of 9 | 0.0 | Waste Management | – | — | — | Industrials | 19.80 $ | -32.3 % | -22.3 % | -16.0 % | −43.2 % | +50.3 % | 10 | 50 | 6.5 % | 6.3 % | 1.66 | 125.4 | 0.0 | — | 1.5 | — | — | 13.0 | — | 40.4 % | 0.7 % | 1.2 % | 1.1 % | 0.88 | — | +19.3 % | 0.0 % | 0.0 % | 4.1 | 99.5 % | 9.4 % | — |
| AMPL Amplitude Inc | 08/05 | -12 % | 20 3/25 | Stage 4 | C -2 | 3 of 9 | 0.9 | Software - Application | – | — | — | Technology | 9.80 $ | -42.5 % | -36.7 % | -42.2 % | −53.4 % | +56.7 % | 10 | 42 | 6.3 % | 6.6 % | 1.45 | — | 44.1 | 2.5 | — | 39.6 | — | -14.3 | — | 73.6 % | -25.1 % | -35.4 % | -14.1 % | — | — | +14.7 % | 0.0 % | 0.0 % | -0.1 | 81.5 % | 8.8 % | — |
| ULH Universal Logistics Holdings Inc | 07/23 | -15 % | 67 8/29 | Stage 4 | D -37 | 3 of 9 | 0.4 | Trucking | – | — | — | Industrials | 14.40 $ | -2.4 % | -2.8 % | -39.4 % | −50.5 % | +11.6 % | 10 | 6 | 6.3 % | 6.6 % | 0.69 | — | 11.2 | 0.3 | 0.8 | — | 3.73 | 15.5 | — | 19.4 % | -7.1 % | -18.5 % | 1.7 % | 1.73 | — | -15.6 % | 2.9 % | 1.6 % | 4.6 | 28.6 % | 11.4 % | — |
| JELD Jeld-Wen Holding Inc | 08/04 | -30 % | 23 4/29 | Stage 4 | D -47 | 3 of 9 | 0.2 | Building Products & Equipmen | – | — | — | Industrials | 1.20 $ | -38.2 % | -43.9 % | -56.8 % | −76.3 % | +18.9 % | 10 | 25 | 12.8 % | 11.4 % | 2.11 | — | 9.3 | 0.0 | 11.7 | — | 2.15 | 74.4 | — | 15.5 % | -16.1 % | -219.2 % | -1.9 % | 115.49 | — | -15.0 % | 0.0 % | 0.0 % | 2.5 | 93.0 % | 14.1 % | — |
| LUNG Pulmonx Corp | 07/29 | -30 % | — | Stage 4 | D -33 | 3 of 9 | 0.0 | Medical Devices | – | — | — | Healthcare | 1.40 $ | -42.1 % | -41.7 % | -45.9 % | −67.8 % | +172.0 % | 10 | 50 | 8.4 % | 7.8 % | 0.31 | — | 28.3 | — | — | — | — | -5.6 | — | 75.5 % | -60.1 % | -86.2 % | -24.0 % | — | — | +8.0 % | 0.0 % | 0.0 % | -9.4 | 79.1 % | 6.4 % | — |
| AEYE AudioEye Inc | 08/06 | +3 % | 20 3/25 | Stage 4 | D -19 | 4 of 9 | 0.1 | Software - Application | – | — | — | Technology | 6.60 $ | -40.1 % | -47.6 % | -47.3 % | −63.5 % | +163.4 % | 10 | 42 | 7.2 % | 6.7 % | 0.82 | — | 7.0 | 1.7 | 24.1 | 11.9 | 2.16 | 567.8 | — | 78.0 % | -9.0 % | -66.9 % | -7.6 % | 5.33 | — | +14.5 % | 0.0 % | 0.0 % | -7.1 | 36.5 % | 5.7 % | — |
| SRTS Sensus Healthcare Inc | 08/06 | -1 % | 83 7/22 | Stage 4 | D -41 | 2 of 9 | 0.0 | Medical Devices | – | — | — | Healthcare | 3.10 $ | -31.2 % | -19.3 % | -34.1 % | −50.2 % | +94.9 % | 10 | 94 | 5.3 % | 5.8 % | 1.09 | — | 400.0 | 1.9 | 1.1 | — | — | 12.8 | — | 37.7 % | -34.5 % | -15.8 % | -13.4 % | 0.01 | — | -34.3 % | 0.0 % | 0.0 % | 15.0 | 29.1 % | 1.3 % | — |
| TELA Tela Bio Inc | 08/10 | -31 % | 94 9/22 | Stage 4 | D -30 | 4 of 9 | 0.0 | Medical Devices | – | — | — | Healthcare | 0.72 $ | -33.4 % | -35.9 % | -56.6 % | −66.4 % | +204.1 % | 10 | 42 | 12.2 % | 11.7 % | 1.34 | — | 0.0 | 0.5 | 7.3 | — | — | -5.0 | — | 67.7 % | -49.3 % | -616.6 % | -28.7 % | -10.84 | — | +15.8 % | 0.0 % | 0.0 % | -14.8 | 69.0 % | 1.0 % | — |
| VGAS Verde Clean Fuels Inc. | 08/12 | -28 % | 99 8/15 | Stage 4 | D -44 | 2 of 9 | 0.1 | Utilities - Renewable | – | — | — | Utilities | 1.10 $ | -22.8 % | -54.1 % | -56.0 % | −59.0 % | — | 10 | 42 | 14.1 % | 10.3 % | -0.32 | — | 0.0 | — | 1.0 | — | — | -0.8 | — | — | 0.0 % | -22.3 % | -11.8 % | 0.02 | — | -100.0 % | 0.0 % | 0.0 % | 25.7 | 6.5 % | 3.6 % | — |
| ACM Aecom Technology Corporation | 08/03 | -5 % | 66 8/29 | Stage 4 | C +3 | 4 of 9 | 8.9 | Engineering & Construction | – | — | — | Industrials | 67.90 $ | -27.1 % | -27.9 % | -36.7 % | −48.2 % | +44.2 % | 9 | 70 | 3.0 % | 3.4 % | 0.93 | 14.6 | 10.1 | 0.6 | 4.0 | 21.6 | 0.68 | 8.4 | 6.7 % | 7.7 % | 3.2 % | 28.6 % | 5.7 % | 1.47 | 18.9 % | +0.2 % | 1.8 % | 21.3 % | 4.0 | 93.8 % | 6.2 % | 1.2 (13) |
| AVAV AeroVironment Inc | — | +21 % | 59 7/29 | Stage 4 | D -11 | 2 of 9 | 6.9 | Aerospace & Defense | – | — | — | Industrials | 142.60 $ | -38.4 % | -46.7 % | -25.7 % | −67.3 % | +89.2 % | 9 | 89 | 5.4 % | 6.4 % | 1.40 | — | 61.0 | 4.3 | 1.6 | — | 1.57 | 69.6 | -5.1 % | 25.3 % | -13.4 % | -8.7 % | -1.3 % | 0.46 | 77.0 % | +14.5 % | 0.0 % | 0.0 % | 8.5 | 89.2 % | 12.6 % | 1.2 (19) |
| G Genpact Limited | 08/06 | -6 % | 61 6/25 | Stage 4 | C +5 | 2 of 9 | 4.7 | Information Technology Servi | – | — | — | Technology | 30.60 $ | -38.9 % | -41.5 % | -30.0 % | −43.1 % | +53.4 % | 9 | 64 | 4.4 % | 4.2 % | 0.62 | 8.8 | 18.5 | 0.9 | 2.0 | 7.1 | 1.16 | 6.3 | 15.4 % | 36.3 % | 11.0 % | 23.1 % | 9.2 % | 2.49 | 44.1 % | +6.6 % | 2.6 % | 19.5 % | 7.0 | 109.3 % | 12.0 % | 1.5 (11) |
| VSTM Verastem Inc | 08/06 | -17 % | 40 4/22 | Stage 4 | D -30 | 3 of 9 | 0.3 | Biotechnology | – | — | — | Healthcare | 5.80 $ | -45.5 % | -51.5 % | -16.7 % | −69.3 % | +338.4 % | 9 | 42 | 8.6 % | 7.4 % | 0.29 | — | 0.0 | 6.1 | 4.1 | — | — | -0.2 | — | 85.1 % | 0.0 % | -786.2 % | -59.4 % | 1.05 | — | +209.1 % | 0.0 % | 0.0 % | -15.1 | 93.6 % | 24.9 % | — |
| NIQ NIQ Global Intelligence plc | 08/13 | — | — | Stage 4 | C -2 | — | 0.0 | — | – | — | — | — | 10.70 $ | -50.9 % | -47.8 % | — | −60.9 % | +81.4 % | 9 | 50 | 5.4 % | 5.7 % | — | — | 9.7 | — | — | — | — | 8.3 | — | — | 0.0 % | 0.0 % | 0.0 % | — | — | — | 0.0 % | 0.0 % | — | 0.0 % | — | — |
| EU enCore Energy Corp. Common Shares | 08/10 | -13 % | — | Stage 4 | D -16 | 4 of 9 | 0.0 | Uranium | – | — | — | Energy | 1.20 $ | -40.3 % | -46.8 % | -40.9 % | −68.2 % | +184.9 % | 9 | 50 | 8.7 % | 8.2 % | 1.27 | — | 10.9 | — | — | — | — | -49.7 | — | -43.3 % | -63.0 % | -12.1 % | -11.5 % | — | — | +1.5 % | 0.0 % | 0.0 % | 4.7 | 50.9 % | 13.5 % | — |
| ALT Altimmune Inc | 08/11 | -9 % | 15 2/22 | Stage 4 | D -16 | 3 of 9 | 0.6 | Biotechnology | – | — | — | Healthcare | 2.80 $ | -19.4 % | -26.1 % | -57.8 % | −62.9 % | +438.3 % | 9 | 42 | 5.4 % | 4.7 % | 0.24 | — | 8.2 | — | — | — | 32.62 | 11.9 | — | -183,477.8 % | 0.0 % | -42.8 % | -24.4 % | — | — | +105.0 % | 0.0 % | 0.0 % | 7.1 | 57.8 % | 21.6 % | — |
| LAB Standard Biotools Inc | 08/10 | -20 % | — | Stage 4 | D -47 | 3 of 9 | 0.0 | Medical Devices | – | — | — | Healthcare | 0.85 $ | -38.1 % | -49.2 % | -38.8 % | −57.0 % | +109.5 % | 9 | 50 | 8.1 % | 8.3 % | 1.42 | — | 0.0 | — | 0.5 | — | — | -19.2 | — | 53.3 % | 90.7 % | -9.9 % | -8.1 % | 0.05 | — | -51.1 % | 0.0 % | 0.0 % | 9.0 | 76.7 % | 4.2 % | — |
| CVRX CVRx Inc | 08/03 | -21 % | 89 8/22 | Stage 4 | D -26 | 3 of 9 | 0.1 | Medical Devices | – | — | — | Healthcare | 4.80 $ | -27.5 % | -22.7 % | -9.9 % | −53.5 % | +112.7 % | 9 | 42 | 6.8 % | 7.0 % | 0.78 | — | 0.0 | 2.4 | — | — | — | -1.3 | — | 86.2 % | -89.1 % | -107.0 % | -27.3 % | — | — | +10.5 % | 0.0 % | 0.0 % | -13.5 | 63.6 % | 9.3 % | — |
Price Chart
Quarterly Figures
No quarterly data available.
Frequently Asked Questions
Relative strength rating ≤ 10 — the weakest ~10% relative to the market.
All scanners are recalculated daily across the entire stock universe — most recently on 21. July 2026. The data basis is fundamental data and SEC filings (10-K annual reports and 10-Q quarterly reports).
Currently, 159 stocks pass this scanner's criteria (as of 21. July 2026). The 25 strongest hits are shown.
Global filters: 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); fundamentally healthy names (Piotroski ≥ 5 or Funda Rating ≥ +10) are excluded.
This scanner deliberately hunts for red flags — a hit is a finding, not a recommendation: like a smoke detector that beeps so you look in time. A hit is also not a bankruptcy verdict; most companies save themselves (say, through a capital raise, which dilutes existing shareholders). Portfolio owners use the list as an early-warning system, bargain hunters as an anti-shopping list, experienced traders as a watch list — it is never a buy or short recommendation.
Related scanners
- Altman Z: Distress Zone
- Below the 50- & 200-SMA
- Beneish M-Score
- Downward Momentum
- Going Concern (Distress Proxy)
- Insolvency Radar: Cash Running Low
- Kathy Donnelly: Liquid Movers Down
- Mike Webster: Overextended (Webby RSI)
- Near 52-Week Low
- Pradeep Bonde: $ Breakout Bearish
- Pradeep Bonde: 4% Breakout Bearish
- Qullamaggie: Parabolic (Short-Watch)
- Stage 4 (Downtrend)
- Stan Weinstein: Stage 4
- Stan Weinstein: Stage 4B-
- Thomas Insolvency Candidate
- Weakness Cluster
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.